Monurol Related Published Studies
Well-designed clinical trials related to Monurol (Fosfomycin)
A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. [2010.12]
Fosfomycin versus other antibiotics for the treatment of cystitis: a
meta-analysis of randomized controlled trials. [2010]
Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. [2009.12]
Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days. [2007.02]
Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. [2005]
Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancer. [2001.03]
Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. [2000.10]
Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. [1999.11]
A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. [1998.04]
Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women. [1994.11]
Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. [1993.12.17]
Introducing fosfomycin for surgical prophylaxis--emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures. [1993]
Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. A randomised double-blind multicentre trial in 517 patients. [1992.03]
Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole. [1992]
Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections. [1991]
Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections. [1991]
Prophylactic single-dose fosfomycin and metronidazole compared with neomycin, bacitracin, metronidazole and ampicillin in elective colorectal operations. [1990.03]
Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study. [1990]
Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection. [1990]
Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy. [1990]
Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly. [1990]
Fosfomycin trometamol versus netilmicin in children's lower urinary tract infections. [1990]
Single-dose fosfomycin trometamol versus multiple-dose cotrimoxazole in the treatment of lower urinary tract infections in general practice. Multicenter Group of General Practitioners. [1990]
A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice. [1990]
Fosfomycin trometamol (Monuril) versus norfloxacin in single dose for adult female uncomplicated UTIs. Multicenter randomized, double-blind study. [1990]
General practitioner study: fosfomycin trometamol versus amoxycillin clavulanate in acute urinary tract infections. [1990]
Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections. [1990]
Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. [1990]
Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. [1990]
Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice. [1990]
[Effects of cefotaxime single administration and of cefotaxime + fosfomycin administration against respiratory tract infections] [1988.09]
Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid. [1987.08]
Well-designed clinical trials possibly related to Monurol (Fosfomycin)
Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. [2010.09.08]
Randomized Controlled Trial of Fosmidomycin-Clindamycin versus Sulfadoxine-Pyrimethamine in the Treatment of Plasmodium falciparum Malaria. [2007.05]
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. [2005.07]
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. [2004.03.01]
Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis. [2003]
Treatment of lower urinary tract infection in pregnancy. [2001.04]
Comparison of the efficacy and safety of amikacin once or twice-a-day in the treatment of severe gram-negative infections in the elderly. [1993.03]
[Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections] [1992.12]
Other research related to Monurol (Fosfomycin)
Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with
pseudomonas airway infection. [2012]
Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients with Pseudomonas Airway Infection. [2011.11.17]
The revival of fosfomycin. [2011.11]
A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates. [2011.08.01]
Disodium-fosfomycin pharmacokinetics and bioavailability in post weaning piglets. [2011.06]
Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses. [2011.02]
Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus. [2011.02]
Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women. [2011.02]
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin. [2011.01]
Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. [2010.11]
Pharmacokinetics of disodium fosfomycin in broilers and dose strategies to comply with its pharmacodynamics versus Escherichia coli. [2010.10]
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection. [2010.10]
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. [2010.09]
A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. [2010.06.29]
Extracellular concentrations of fosfomycin in lung tissue of septic patients. [2010.05]
Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections. [2010.04.15]
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. [2010.04]
[Fosfomycin: past, present and future]. [2010.04]
Fosfomycin: an old, new friend? [2010.02]
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. [2010.02]
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. [2010.01]
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. [2009.12]
[In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections] [2009.10]
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. [2009.10]
CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. [2009.10]
Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. [2009.09.20]
High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. [2009.09]
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. [2009.08]
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. [2009.07]
Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses. [2008.08]
Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? [2008.08]
Pharmacokinetics of disodium-fosfomycin in mongrel dogs. [2008.08]
[Fosfomycin prescription during production shortage] [2008.07]
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin. [2008.06]
Fosfomycin: use beyond urinary tract and gastrointestinal infections. [2008.04.01]
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin. [2008.01.23]
Feasible identification of Staphylococcus epidermidis using desferrioxamine and fosfomycin disks. [2008.01]
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. [2008.01]
Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery. [2007.10]
Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. [2007.10]
Safety of ofloxacin (OFLX) and fosfomycin sodium (FOM) ear drops. [2007.06]
Immunomodulatory effects of fosfomycin in experimental human endotoxemia. [2007.05]
Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy? [2007.05]
Fosfomycin--investigation of a possible new route of administration of an old drug. A case study. [2007.05]
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. [2007.01]
[Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus] [2007]
[Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery] [2006.12]
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae] [2006.12]
[Fosfomycin trometamol: multiple-dose regimen for the treatment of lower urinary tract infections] [2006.11]
[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?] [2006.10]
Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy? [2006.08.29]
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration. [2006.08]
Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. [2006.05]
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. [2006.05]
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. [2005.11]
Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin. [2005.10]
Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa. [2005.05.06]
Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study. [2005.05]
The effect of fosfomycin on nedaplatin-induced nephrotoxicity in rats. [2005.02]
Differential effects of fosfomycin and corticosteroid on the molar ratio of interleukin-1 receptor antagonist/interleukin-1beta in the culture supernatants of mononuclear phagocytes from patients with sarcoidosis. [2004.10]
Capillary electrophoresis analysis of fosfomycin in biological fluids for clinical pharmacokinetic studies. [2004.07]
|
